The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Narachi Michael since 2012.
The trader's CIK number is 1380022.
At the time of the last reporting, Narachi Michael was the Director of Orexigen Therapeutics, Inc.. (stock ticker symbol OREXQ).
Also see all insider trading activities at Orexigen Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | CLDN | 62,500 | $500,000 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2014 | OREX | 50,000 | $239,100 | 0 | $0 | 0 | $0 |
| 2012 | OREX | 0 | $0 | 525,000 | $3,479,884 | 525,000 | $874,500 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2012 | AMAG | 7,500 | $27,102 | 0 | $0 | 0 | $0 |
1. Eiger Biopharmaceuticals, Inc. (CLDN)
2. Orexigen Therapeutics, Inc. (OREX)
3. Amag Pharmaceuticals, Inc. (AMAG)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-02-04 | CLDN | Buy | 62,500 | 8.00 | 500,000 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2014-09-15 | OREX | Buy | 50,000 | 4.78 | 239,100 |
| 2012-07-17 | OREX | Option Ex | 150,000 | 1.68 | 252,000 |
| 2012-07-17 | OREX | Sale | 150,000 | 7.66 | 1,149,000 |
| 2012-07-13 | OREX | Sale | 147,100 | 6.70 | 985,570 |
| 2012-07-12 | OREX | Option Ex | 2,900 | 1.66 | 4,814 |
| 2012-07-13 | OREX | Option Ex | 147,100 | 1.66 | 244,186 |
| 2012-07-12 | OREX | Sale | 2,900 | 6.66 | 19,314 |
| 2012-06-28 | OREX | Sale | 100,000 | 5.66 | 566,000 |
| 2012-06-29 | OREX | Sale | 125,000 | 6.08 | 760,000 |
| 2012-06-28 | OREX | Option Ex | 100,000 | 1.66 | 166,000 |
| 2012-06-29 | OREX | Option Ex | 125,000 | 1.66 | 207,500 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2012-05-24 | AMAG | Buy | 2,000 | 13.55 | 27,102 |
| 2012-05-25 | AMAG | Buy | 5,500 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Narachi Michael (Director of Orexigen Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.